News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
TMX Newsfile
NEWS
IN THE PRESS
Press Releases
Theralase(R) Closes $1.3 M Non-Brokered Private Placement
December 23, 2025
·
5 min read
Press Releases
A Year of Purpose and Progress: Dr. Christina Rahm Celebrates Global Growth, Scientific Breakthroughs, and International Honors
December 23, 2025
·
6 min read
Press Releases
Hemostemix Appoints Dr. David B. Alper, to Lead Multidisciplinary Physician Education in the Use of ACP-01
December 23, 2025
·
9 min read
Press Releases
Phio Pharmaceuticals Announces Significant Step Forward in its Drug Development Program for PH-762
December 23, 2025
·
5 min read
Press Releases
BioMark Diagnostics Advances Commercialization Strategy by Initiating ISO 15189 Accreditation Program
December 23, 2025
·
3 min read
Press Releases
Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan
December 22, 2025
·
5 min read
Press Releases
Entheon Announces Letter of Intent with Nutravisor Inc.
December 22, 2025
·
7 min read
Press Releases
Restart Life Sciences Signs Binding LOI to Acquire The Holy Crap Foods Portfolio of Brands and Manufacturing Plant
December 22, 2025
·
9 min read
Press Releases
Sharp Therapeutics Provides Update on Non-Brokered Private Placement and Grant of Options
December 19, 2025
·
6 min read
Press Releases
Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program
December 18, 2025
·
6 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us